Skip to main content
Danica Wiredja, MD, Pathology, Stanford, CA

DanicaWiredjaMD

Pathology Stanford, CA

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Physician

Dr. Wiredja is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wiredja's full profile

Already have an account?

  • Office

    300 Pasteur Drive
    Edwards Building R204
    Stanford, CA 94305
    Phone+1 650-721-5755

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Molecular Genetic Pathology, 2022 - 2023
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityChief Residency, Pathology-Anatomic and Clinical, 2021 - 2022
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 2019 - 2022
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2015

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2026
  • CO State Medical License
    CO State Medical License 2023 - 2025
  • American Board of Pathology Pathology - Clinical
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Journal Articles

  • A Spurious Positive Result on the Abbott Architect 4th generation HIV Ag/Ab Combo Assay in a Low-Risk Patient.  
    Pepper MA, Wiredja DD, Patel PM, Stevens BA, Pinsky BA, Shi RZ., Clin Chim Acta.
  • Global Phosphoproteomics of CCR5-Tropic HIV-1 Signaling Reveals Reprogramming of Cellular Protein Production Pathways and Identifies p70-S6K1 and MK2 as HIV-Responsive...  
    Danica Wiredja, MD, BioMed Central